Conditions for collection of serum samples for the measurement of fibrin(ogen) degradation products by radioimmunoassay of fragment E.

A number of conditions have been assessed for the collection of serum samples for the measurement of fibrin(ogen) degradation products using a radioimmunoassay for degradation fragment E, which permits precise quantitation of differences. Blood should be collected using minimal venous occlusion into glass tubes containing 10 mg/ml of epsilon amino caproic acid and allowed to clot at 4 to 20 degrees C for at least 4 hours before centrifugation. The serum may be stored at 4 or -20 degrees C. Samples from patients receiving anticoagulant therapy should be treated with 10 IU of thrombin per ml.

[1]  C. Hawkey,et al.  The Influence of Beta-adrenergic Blockade upon Baseline Blood Coagulation and Fibrinolytic Activity and upon the Responses to Venous Occlusion , 1975, Thrombosis and Haemostasis.

[2]  T. Chard,et al.  The Development of Radioimmunoassays for Fibrinogen Degradation Products: Fragments D and E , 1975, British journal of haematology.

[3]  P. Gaffney,et al.  Plasma Fibrinogen and its Fragments during Streptokinase Treatment , 1974, British journal of haematology.

[4]  V. Gurewich,et al.  INTRAVASCULAR COAGULATION DURING PREGNANCY AND THE PUERPERIUM , 1973, The Journal of obstetrics and gynaecology of the British Commonwealth.

[5]  R. Winston,et al.  Serum and Urine Fibrinogen Derivatives in Normal Pregnancy and Preeclampsia , 1973, Obstetrics and gynecology.

[6]  T. Chard,et al.  Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. , 1973, Lancet.

[7]  M. Koenig,et al.  Degradation products of fibrinogen and fibrin in bacteremia due to gram-negative rods. , 1973, The Journal of infectious diseases.

[8]  T. Edgington,et al.  Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. , 1973, The Journal of clinical investigation.

[9]  J. Briggs,et al.  Serum and Urine Fibrinogen-Fibrin-related Antigen (F.R.-Antigen) Levels in Renal Disease , 1972, British medical journal.

[10]  I. Nilsson,et al.  Serum fibrin-fibrinogen degradation products in acute myocardial infarction. , 1972, Lancet.

[11]  R. Chakrabarti.  SERUM FIBRIN/FIBRINOGEN DEGRADATION PRODUCTS IN ACUTE MYOCARDIAL INFARCTION , 1972 .

[12]  P. Lalezari,et al.  Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. , 1972, The Journal of clinical investigation.

[13]  R. Biggs.  Human blood coagulation, haemostasis and thrombosis; , 1972 .

[14]  M. Allington.  Detection of fibrin(ogen) degradation products by a latex clumping method. , 1971, Scandinavian journal of haematology. Supplementum.

[15]  Francis J. Castellino,et al.  The Mechanism of the Inhibition of Plasmin Activity by ε-Aminocaproic Acid , 1971 .

[16]  Z. Wegrzynowicz,et al.  Degradation of fibrinogen by proteolytic enzymes. , 1971, Scandinavian journal of haematology. Supplementum.

[17]  D. Pugsley,et al.  Fibrin degradation products in pre-eclamptic toxaemia and eclampsia. , 1971, British medical journal.

[18]  E. Stiehm,et al.  Split products of fibrin in maternal serum in the perinatal period. , 1970, American journal of obstetrics and gynecology.

[19]  A. S. Douglas,et al.  Fibrin Degradation Products in Normal and Abnormal Pregnancy and Parturition , 1969, British medical journal.

[20]  V. Marder,et al.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. , 1969, The Journal of biological chemistry.

[21]  C. Merskey,et al.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. , 1966, Blood.

[22]  I. Nilsson,et al.  DEMONSTRATION OF FIBRINOLYTIC SPLIT PRODUCTS IN HUMAN SERUM BY AN IMMUNOLOGICAL METHOD IN SPONTANEOUS AND INDUCED FIBRINOLYTIC STATES. , 2009, Scandinavian journal of haematology.